Bangladesh pharma market dynamics 2 q 2012
Upcoming SlideShare
Loading in...5
×
 

Bangladesh pharma market dynamics 2 q 2012

on

  • 1,303 views

 

Statistics

Views

Total Views
1,303
Views on SlideShare
1,303
Embed Views
0

Actions

Likes
0
Downloads
45
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Bangladesh pharma market dynamics 2 q 2012 Bangladesh pharma market dynamics 2 q 2012 Presentation Transcript

  • Pharma Market Dynamics2Q 2012
  • • Confidentiality StatementThis presentation is solely for the use of IMS clients. No part of itmay be circulated, quoted or reproduced for distribution outside ofthe client organization without prior written approval of IMS Health
  • • Bangladesh Pharma Market
  • Bangladesh pharma market: Eskayef is the number6 company with 4.74% market share418.429.528.885.33 4.93 4.74 4.31 4.12 4.03 3.73SQUARE INCEPTA BEXIMCO OPSONIN RENATA ESKAYEF A.C.I. ACME ARISTO DRUGINTLShare %
  • Evolution of market share: Top 10 CompaniesRecent data indicates good performance of Incepta, Opsonin,Renata & DI5MAT ~ 06/2012 YTD ~ 06/2012 QTR ~ 06/2012SQUARE 18.42 18.17 17.13INCEPTA 9.52 9.70 9.78BEXIMCO 8.88 8.75 8.49OPSONIN 5.33 5.44 5.47RENATA 4.93 5.02 5.14ESKAYEF 4.74 4.74 4.71A.C.I. 4.31 4.16 4.22ACME 4.12 4.20 4.07ARISTO 4.03 4.08 4.07DRUG INTL 3.73 3.83 3.97
  • • The Antibiotics Molecules
  • Antibiotic Market: Top 12 Molecules represents 90%of the 1700 Crore Taka Market717.6315.7911.8510.967.686.59 6.555.472.681.98 1.81 1.32Share %
  • Clindamycin (39% gr) is the highest growingmolecule, followed by Cefuroxime (19% gr)838.8019.39 18.12 17.7615.736.650.65 0.33-4.11 -4.32 -5.57-10.29Growth %
  • Top Companies in Antibiotic Market: ESK number 8Renta 3, ACI 5, Sanofi 9922.297.476.77 6.43 6.165.20 5.11 5.09 4.753.47SQUARE INCEPTA RENATA BEXIMCO A.C.I. ACME OPSONIN ESKAYEF SANOFIAVNARISTOShare %
  • Antibiotic Market: Incepta & Opsonin have highgrowth1022.297.476.77 6.43 6.165.20 5.11 5.09 4.753.476.9923.9712.998.8512.671.2717.679.736.194.45SQUARE INCEPTA RENATA BEXIMCO A.C.I. ACME OPSONIN ESKAYEF SANOFIAVNARISTOShare % Growth %
  • Antibiotic Market: 4 companies in top 10 are loosingshare1122.297.47 6.77 6.43 6.165.20 5.11 5.09 4.753.47-1.1114.574.480.634.05-6.478.721.39-2.06-3.34SQUARE INCEPTA RENATA BEXIMCO A.C.I. ACME OPSONIN ESKAYEF SANOFIAVNARISTOShare % Share Growth %
  • • Cefuroxime Axetil Market
  • 13Cefuroxime Market: 78% mkt in 3 divisions:90% in 4 divisionsDhaka37%Chittagong21%Rajshahi20%Khulna12%Barisal6%Sylhet4%Share %
  • 14Cefuroxime: market growth is driven by North BengalGrowth in DHK & CHT is lower than national growth (19%)37.4020.77 19.7312.136.043.9316.7114.2027.9019.1429.9720.02Dhaka Chittagong Rajshahi Khulna Barisal SylhetShare % Growth %
  • 15Kilmax: DHK division doing wonderful!Under-performing in North Bengal & Barisal5.134.364.074.513.564.79Dhaka Chittagong Rajshahi Khulna Barisal SylhetMS %
  • 16Kilmax: DHK having high MS, still growingGrowth improvement opportunity in CHT5.13 4.36 4.07 4.51 3.56 4.7937.67-0.2047.6513.5249.849.43Dhaka Chittagong Rajshahi Khulna Barisal SylhetMS % Gr %
  • 17Furosef VS. Kilmax: High market share gap (13%) inCHT, low gap in RAJ (7%)17.1917.8111.6615.53 15.4917.555.134.36 4.07 4.513.564.79Dhaka Chittagong Rajshahi Khulna Barisal SylhetMS %FUROCEF-RTA KILMAX-ESF
  • 18Kilbac Vs. Kilmax: High market share gap in CHT13.0514.6010.86 11.20 11.5610.875.134.36 4.07 4.513.564.79Dhaka Chittagong Rajshahi Khulna Barisal SylhetMS %KILBAC-IAP KILMAX-ESF
  • 19Kilbac Vs. Kilmax: GAP Analysis7.9210.246.79 6.698.006.08Dhaka Chittagong Rajshahi Khulna Barisal SylhetKIlbac VS. KilmaxGAP
  • 20Top 5 District: Kilmax MS% high in MymensinghLow in Comilla4.084.825.503.464.21Dhaka Chittagong Mynensingh Comilla KhulnaKilmaxShare %
  • 21Top 5 District: Kilmax growth % high in MymensinghNegative in Chittagong9.9617.1229.0620.87 18.9128.29-5.2990.0039.85 36.93Dhaka Chittagong Mynensingh Comilla KhulnaMarket GrowthMarket Kilmax
  • • Clindamycin Market
  • 23Clindamycin Market: Dhaka and Rajshahi divisiondominates the marketDhaka39%Rajshahi25%Khulna14%Chittagong14%Barisal5%Sylhet3%Share %
  • 2439.3924.7514.36 13.854.40 3.2545.8753.8329.8311.1941.7123.91Dhaka Rajshahi Khulna Chittagong Barisal SylhetShare % Growth %Clindamycin Market: Very high growth for Dhaka,Rajshahi & Barisal division
  • 25Incepta VS. Opsonin: Market share GAP is low (7%GAP) in DHK; High in KHL (18%)31.3434.5139.6036.9631.67 30.3423.96 23.6221.3523.8028.0225.74Dhaka Rajshahi Khulna Chittagong Barisal SylhetCLINDACIN-IAP CLINDAX-OPI
  • 26Incepta VS. Opsonin: Clindax growth is better thanClindacin in all divisionsMajor growth difference in Dhaka & Barisal division11.6625.446.68-8.128.52-4.8960.1237.5710.613.0040.4323.78Dhaka Rajshahi Khulna Chittagong Barisal SylhetCLINDACIN-IAP CLINDAX-OPI
  • • The Anti-ulcer Market
  • Anti-ulcer Market: 3 ESF brands in top 50 ;QTR figure is encouraging28RK~MAT06/2012RK~YTD06/2012RK~QTR06/2012LOSECTIL 2 2 1PEPTIL-H 21 28 26ESORAL 29 21 17
  • • Omeprazole Market
  • 30Omeprazole Market: 60% mkt in 2 divisions:90% in 4 divisionsDhaka34%Chittagong24%Rajshahi19%Khulna12%Barisal7%Sylhet4%Share %
  • 31Losectil in Omeprazole Market: High MS in KHLWhatever happened in BSL?19.36 19.21 18.9622.3113.9421.82Dhaka Chittagong Rajshahi Khulna Barisal SylhetLosectilShare %
  • 32Losectil in Omeprazole Market: High Growth in KHLLower growth in DHK19.36 19.21 18.96 22.3113.9421.8222.0937.14 28.15100.2140.3149.52Dhaka Chittagong Rajshahi Khulna Barisal SylhetLosectilShare % Growth %
  • 33Seclo Vs. Losectil: market share equally low in alldivisionsStill losing ground in DHK, RAJ, KHL, SYL19.36 19.21 18.9622.3113.9421.8228.2027.06 26.19 26.7428.1019.15Dhaka Chittagong Rajshahi Khulna Barisal SylhetMS %Losectil Seclo
  • 34Seclo Vs. Losectil: Low gap in KHLLosectil beats Seclo in SYL!8.84 7.85 7.234.4314.16-2.67Dhaka Chittagong Rajshahi Khulna Barisal SylhetLosectil Vs. SecloGAP
  • 35Losectil Share % in 5 Major District: High in CHTLow in COM, MYM20.7423.4813.9217.2819.67Dhaka Chittagong Comilla Mynensingh KhulnaMS %LOSECTIL
  • 36Seclo Vs. Losectil: 5 Major District20.7423.4813.9217.2819.6727.87 27.34 26.8336.1224.00Dhaka Chittagong Comilla Mynensingh KhulnaMS %LOSECTIL SECLO
  • 37GAP Analysis in District Level:High gap in MYM & COM7.133.8612.9118.844.33Dhaka Chittagong Comilla Mynensingh KhulnaGAP20.7423.4813.9217.2819.6727.87 27.34 26.8336.1224.00Dhaka Chittagong Comilla Mynensingh KhulnaMS %LOSECTIL SECLO
  • • Esomeprazole Market
  • 39Esomeprazole: Share is good in DHK & BSLLot of works to be done in North Bengal3.903.382.943.79 3.913.41Dhaka Chittagong Rajshahi Khulna Barisal SylhetEsoralShare %
  • 40Esomeprazole Market Vs. Esoral Growth51.6738.7279.4661.6073.7455.42199.39154.03218.22 208.34 206.15161.73Dhaka Chittagong Rajshahi Khulna Barisal SylhetGrowth %Esomeprazole Esoral
  • 41Maxpro Vs. Esoral: Where is the biggest gap?24.36 24.8119.5721.6425.4319.443.90 3.38 2.94 3.79 3.91 3.41Dhaka Chittagong Rajshahi Khulna Barisal SylhetMS %Maxpro Esoral
  • 42Maxpro Vs. Esoral: High GAP in CHT & BSL20.46 21.4316.6317.8521.5216.03Dhaka Chittagong Rajshahi Khulna Barisal SylhetMaxpro Vs. EsoralGAP
  • 43Esoral in Top 5 DistrictDhaka Chittagong Comilla Khulna Mynensingh1 MAXPRO RTAMAXPRORTAMAXPRORTA MAXPRO RTAMAXPRORTA2 SERGEL HT3 SERGEL HT3SERGELHT3 SERGEL HT3NEXUMSQA3 NEXUM SQASOMPRAZSPINEXUMSQA ESONIX IAPSERGELHT34 ESONIX IAP ESONIX IAPEXIUMRD7 MAXIMA ACMEXIUMRD75 EXIUM RD7 NEXUM SQA ESONIX IAP NEXUM SQA ESONIX IAP6 ESOTID OPI EXIUM RD7SOMPRAZSPI EXIUM RD7ESORALESF7 ESORAL ESF ESORAL ESFESOTIDOPI PROGESIC IAPESOTIDOPI8 PROGESIC IAP ESOTID OPI NESO ATP SOMPRAZ SPIPROGUTPPH9 NEPTOR SDZ ESOLOK IBNESORALESF ESOTID OPISOMPRAZSPI10 NESO ATPPROGUTPPHMAXIMAACM NESO ATPOPTONBXM?
  • • The Anti-ulcer Market:• Promotional Preference
  • 45CHT: Important for Ranitidine market24.26 23.71 23.11 22.7227.96Omeprazole Pantoprazole Esomeprazole Rabeprazole RanitidineChittagong
  • 46RAJ: Important for Pantoprazole18.5519.8818.6717.0415.76Omeprazole Pantoprazole Esomeprazole Rabeprazole RanitidineRajshahi
  • 47DHK: Important for Rabeprazole & Ranitidine34.1834.7734.9736.4736.11Omeprazole Pantoprazole Esomeprazole Rabeprazole RanitidineDhaka